VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES'' or the
"Company”), a cognitive computing company specializing in
biologically inspired distributed intelligence, today announced a
partnership with Cortical Labs, a biological hardware startup that
is seeking to revolutionize computing by fusing live neurons with
silicon chips.
The partnership between VERSES and Cortical Labs marks an
alignment of philosophies around the future of computing between
software patterned after algorithms found in nature and hardware
constructed from brain cells. Cortical Labs, recently backed by
billionaire Li Ka Shing and In-Q-Tel, the venture capital arm of
the Central Intelligence Agency (CIA), are the creators of
DishBrain - a synthetic biological computer consisting of 800,000
neurons, grown in-vitro, capable of performing goal-directed tasks,
such as playing the tennis-like computer game Pong.
“Cortical Labs’ research results show that active inference is a
beneficial approach when teaching neurons grown in vitro to perform
tasks and we are thrilled to announce that we plan to continue this
research in partnership with Cortical Labs. The VERSES research
team will be exploring the development of novel algorithms that
leverage Cortical Labs’ synthetic biological intelligence systems
with the aim of solving real-world problems. Over the years,
GPU-based systems have continued to yield major breakthroughs and
impressive results, but we believe that path is not sustainable. We
seek to find not only new software but new hardware solutions that
embody the efficiencies found in nature,” said VERSES CTO Jason
Fox.
Some of Cortical Labs' work is based on the free energy
principle, which was developed by VERSES Chief Scientist Karl
Friston, whose impact on the understanding of how biological
systems work has been linked to Darwin’s theory of evolution by
natural selection.
“Our research concludes that biological processes are more
energy efficient than current GPU technologies and have a higher
sample efficiency for training than current state-of-the-art
reinforcement learning techniques. We hope this will result in
greater accessibility to the technology regarding cost and, more
importantly, a lower environmental footprint than traditional AI to
make and operate. We are excited to form this partnership with
VERSES and collaborate on innovative ways to advance our
technologies,” said Hon Weng Chong, M.D. Founder and CEO, Cortical
Labs.
Cortical Labs joins VERSES’ beta partnership program, which
intends to feature ten partners across multiple industries and of
various sizes and stages interested in using VERSES’ Genius™
platform to deploy smarter and safer intelligent software.
About Cortical Labs
Cortical Labs is a biological computing startup putting live
neurons into chips to revolutionize computing. Cortical Labs
specialties include machine learning, neuroscience, neural
engineering, brain-computer interface, artificial intelligence,
computational cognitive neuroscience, reinforcement learning, deep
learning, neural networks, medical artificial intelligence and
robotics. For more information, visit:
https://corticallabs.com/
About VERSES
VERSES AI is a cognitive computing company specializing in
biologically inspired distributed intelligence. Our flagship
offering, Genius™, is patterned after natural systems and
neuroscience. Genius can learn, adapt, and interact with the world.
Key features of Genius™ include generalizability, predictive
queries, real-time adaptation and an automated computing network.
Built on open standards, Genius™ transforms disparate data into
knowledge models that foster trustworthy collaboration between
humans, machines and AI, across digital and physical domains.
Imagine a smarter world that elevates human potential through
innovations inspired by nature. Learn more at VERSES, LinkedIn and
Twitter.
On behalf of the Company
Eric Holder, Director of Communications, VERSES AI Inc.
press@verses.ai
Investor Relations Inquiries
U.S. Matthew Selinger, Partner, Integrous Communications,
mselinger@integcom.us
Canada Leo Karabelas, President, Focus Communications,
info@fcir.ca
Forward Looking Information
This press release contains "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation (collectively, “forward-looking
statements”). The forward-looking statements herein are made as of
the date of this press release only, and the Company does not
assume any obligation to update or revise them to reflect new
information, estimates or opinions, future events or results or
otherwise, except as required by applicable law. Often, but not
always, forward-looking statements can be identified by the use of
words such as "plans", "expects", "is expected", "budgets",
"scheduled", "estimates", "forecasts", "predicts", "projects",
"intends", "targets", "aims", "anticipates" or "believes" or
variations (including negative variations) of such words and
phrases or may be identified by statements to the effect that
certain actions "may", "could", "should", "would", "might" or
"will" be taken, occur or be achieved. These forward-looking
statements include, among other things, statements relating to: the
partnership between VERSES and Cortical Labs; the sustainability of
GPU-based systems as it pertains to its ability to continue to
yield major breakthroughs and impressive results; the Company’s
goals as it relates to software and hardware solutions; the fact
that the Company’s research team will be exploring the development
of novel algorithms that leverage Cortical Lab’s synthetic
biological intelligence systems with the aim of solving real word
problems; the anticipated benefits of including biological
processes in technology; and the Company’s beta partnership
program, including the number of partners the Company expects to
feature.
Such forward-looking statements are based on a
number of assumptions of management, including, without limitation,
that the Genius™ beta program will proceed as expected; that the
Company’s partnership with Cortical Labs will proceed as currently
contemplated and that such partnership will result in the benefits
and developments currently expected; that VERSES and Cortical Lab’s
philosophies are aligned; that the Company will develop novel
algorithms that leverage Cortical Lab’s biological intelligence
systems; that research results are correct in showing that active
inference is a beneficial approach when teaching neurons grown in
vitro to perform tasks; that GPU-based systems will not continue to
yield major breakthroughs and impressive results and that they are
not sustainable;; that there are benefits to the inclusion of
biological processes in technology; that the Company will find new
software and hardware solutions that embody the efficiencies found
in nature, and that will be helpful in solving real world problems;
that the Company will be successful in the deployment of its
resources and personnel; that results of testing and development
data will be consistent with anticipated results and estimates;
that the Company will not come across technology or other barriers
preventing it from achieving its business objectives and
commercializing the Genius™ technology; and that the Company’s
technology will impact the AI market and the Company’s success in
the AI market as anticipated.
Additionally, forward-looking statements involve a variety of
known and unknown risks, uncertainties and other factors which may
cause the actual plans, intentions, activities, results,
performance or achievements of the Company to be materially
different from any future plans, intentions, activities, results,
performance or achievements expressed or implied by such
forward-looking statements. Such risks include, without limitation:
the Company’s operations could be adversely affected by possible
future government legislation, policies and controls or by changes
in applicable laws and regulations including the ability of the
Company to develop and commercialize its products and the release
and deployment of the Genius™ technology and its other
technologies; political instability; unexpected development and
production challenges; the Company could face technology or
software disruptions; unanticipated costs; the Genius™ technology
may fail to perform as expected; the Genius beta partnership
program may not proceed as expected; the partnership with Cortical
Labs may fail to yield the expected benefits; VERSES and Cortical
Lab’s philosophies around the future of computing may fail to
align; active inference may not be a useful approach when teaching
neurons grown in vitro to perform tasks; the Company may be unable
to develop novel algorithms to leverage the synthetic biological
intelligence systems of Cortical Labs; the inclusion of biological
processes in technology may not yield the expected benefits; the
Company may not be successful in finding new software and hardware
solutions which embody the efficiencies found in natures; the
partnership between VERSES and Cortical Labs may not advance the
companies technologies; the loss of key personnel; and the loss of
key partnerships necessary for the Company to achieve its business
objectives.
The forward-looking statements contained in this press release
represent management's best judgment based on information currently
available. No forward-looking statement can be guaranteed and
actual future results may vary materially. Accordingly, readers are
advised not to place undue reliance on forward-looking statements.
Neither the Company nor any of its representatives make any
representation or warranty, express or implied, as to the accuracy,
sufficiency or completeness of the information in this press
release. Neither the Company nor any of its representatives shall
have any liability whatsoever, under contract, tort, trust or
otherwise, to you or any person resulting from the use of the
information in this press release by you or any of your
representatives or for omissions from the information in this press
release.
Proshares Metaverse ETF (AMEX:VERS)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Proshares Metaverse ETF (AMEX:VERS)
Historical Stock Chart
Von Mai 2023 bis Mai 2024